Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.84 |
| ▸ | NPC1 | O15118 | 1/20 | 0.81 |
| ▸ | RAB9A | P51151 | 1/20 | 0.81 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.71 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | BCHE | P06276 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7854448 | 0.91 | POLB (0.92) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL7006523 | 0.91 | POLB (1.00) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL30583066 | 0.90 | RAB9A (1.00) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL784574 | 0.90 | RAB9A (1.00) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL7856311 | 0.90 | POLB (0.96) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL7854826 | 0.90 | POLB (0.96) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL30701864 | 0.90 | POLB (0.96) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL4249670 | 0.90 | POLB (0.75) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL7856315 | 0.90 | POLB (0.96) | POLBNPC1RAB9APDE10ADDAH1 | |
| SCHEMBL30701863 | 0.90 | POLB (0.96) | POLBNPC1RAB9APDE10ADDAH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8182718-B2 | Ligand exchange thermochromic systems and high ε ligands for same | PLEOTINT, L.L.C. (US) | 2012-05-22 | — | — | US | claimed |
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4347544-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | Dow Technology Investments LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| CN-117242047-A | Process for the vapor phase hydrogenation of aldehydes | 陶氏技术投资有限责任公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-116810216-A | Water-soluble pre-flux and surface treatment method | 株式会社田村制作所 | 2023-09-29 | — | — | CN | disclosed |
| EP-3196048-B1 | RUBBER COMPOSITION FOR TIRES, PNEUMATIC TIRE, AND AN AIRLESS TIRE | SUMITOMO RUBBER IND (JP) | 2020-12-16 | — | — | EP | disclosed |
| US-10507692-B2 | Rubber compound for tires, pneumatic tire, and an airless tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2019-12-17 | — | — | US | disclosed |
| EP-2970074-B1 | HYDROFORMYLATION PROVESS USING A HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2019-04-24 | — | — | EP | disclosed |
| US-20170305192-A1 | RUBBER COMPOUND FOR TIRES, PNEUMATIC TIRE, AND AN AIRLESS TIRE | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2017-10-26 | — | — | US | disclosed |
| EP-2526129-B1 | ETHYLENE POLYMERISATION PROCESS | SAUDI BASIC IND CORP (SABIC) (SA) | 2017-09-27 | — | — | EP | disclosed |
| US-6255091-B1 | ASSAYING FOR ENHANCED INHIBITION OF SERINE PROTEASE IN A MEDIUM THAT IS DEVOID OF DISSACIATED DIVALENT METAL CATIONS | AXYS PHARMACEUTICALS, INC. | 2001-07-03 | — | — | US | disclosed |
| EP-0943008-A1 | METAL MEDIATED SERINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 1999-09-22 | — | — | EP | disclosed |
| EP-0791671-B1 | Surface treating agent for copper or copper alloy | SHIKOKU CHEM (JP) | 1999-06-16 | — | — | EP | disclosed |
| EP-0873292-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1998-10-28 | — | — | EP | disclosed |
| US-5795409-A | MIXTURE OF A (BENZ)IMIDAZOLE COMPOUND, CHELATE COMPOUND AND IRON | SHIKOKU CHEMICALS CORPORATION (JP) | 1998-08-18 | — | — | US | disclosed |
| WO-1998022619-A1 | METAL MEDIATED SERINE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-05-28 | — | — | WO | disclosed |
| US-5731472-A | HETEROCYCLIC NITROGEN COMPOUNDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1998-03-24 | — | — | US | disclosed |
| EP-0791671-A1 | Surface treating agent for copper or copper alloy | SHIKOKU CHEMICALS CORPORATION (JP) | 1997-08-27 | — | — | EP | disclosed |
| WO-1997020798-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
| US-3955920-A | ION EXCHANGING | HENKEL & CIE G.M.B.H. (DT) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240174583-A1 | PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES | ADH1C, ADH5, ALDH2 | POLB 32/4885NPC1 4654/4885RAB9A 2415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.